Intel said on Monday it plans to raise about $15 billion through a share offering, turning to investors to help finance an expensive expansion of its contract chip manufacturing business as a sharp recovery in its stock gives the struggling semiconductor giant an opportunity to strengthen its balance sheet.
Intel shares fell more than 4% in early trading after the announcement, as investors weighed the potential dilution against the company’s need for capital to execute its foundry strategy. The stock had nearly tripled this year through Friday’s close, substantially outperforming AMD and Nvidia and the roughly 75% gain in the Philadelphia Semiconductor Index.
The planned equity raise comes at a critical point in Intel’s attempt to rebuild its manufacturing capabilities and establish itself as a credible alternative to Taiwan Semiconductor Manufacturing Co. in contract chip production.
Intel has been investing heavily in new fabrication plants, advanced packaging and next-generation manufacturing processes as it seeks to reverse years of manufacturing setbacks and compete for business from companies that historically relied on Asian foundries.
Intel’s shares have surged on expectations that Chief Executive Lip-Bu Tan’s turnaround strategy can restore the company’s position in advanced chip manufacturing. That rally has also substantially lowered the relative cost of raising equity compared with doing so when the stock was trading near its recent lows.
“Intel is a capital-intensive business that went a long way to wrecking its own balance sheet and prospects by focusing on financial engineering rather than physical engineering,” said Russ Mould, investment director at AJ Bell, referring to the company’s $82 billion of share buybacks during the 2010s.
“Especially after a five-fold increase in the stock price since last August,” he said, raising capital now makes sense.
The capital-intensive nature of Intel’s strategy is becoming increasingly apparent. The company raised its 2026 capital expenditure forecast to $20 billion from $18 billion in July as demand for central processing units increases alongside the expansion of AI agents and other AI workloads.
Intel is simultaneously trying to finance a major transformation of its manufacturing operations while developing products capable of competing in an AI market dominated by Nvidia.
The company’s foundry strategy is arguably the more consequential part of the turnaround. Intel wants to manufacture chips designed by other companies, effectively competing for business with TSMC while using its own manufacturing infrastructure to restore the economics of its semiconductor operations.
That strategy requires enormous upfront investment before revenue from customers reaches sufficient scale. Intel’s latest capital raise therefore provides additional financial capacity at a time when the company is committing billions of dollars to facilities that may take years to reach full commercial utilization.
The company has also made progress in securing potential customers for its most advanced manufacturing technology. Intel said it had committed to high-volume production using its 14A process in 2028, reversing an earlier warning that the technology could be abandoned without a major external customer.
Tesla has been identified as a 14A customer, while expectations of another major customer increased after President Donald Trump said Apple would manufacture processors with Intel. Neither Apple nor Intel has confirmed that arrangement.
If Apple ultimately becomes a major Intel foundry customer, it could significantly strengthen the credibility of Intel’s strategy. Apple is one of the world’s largest semiconductor buyers and has extensive experience using TSMC for the manufacture of its processors.
Intel is also expanding its international manufacturing footprint. Last month, it announced a €5 billion ($5.77 billion) investment to upgrade and expand its chip manufacturing operations in Ireland. The project represents more than a quarter of the company’s planned capital spending for 2026. That spending highlights the scale of the challenge facing Intel. The company is effectively trying to rebuild its manufacturing advantage while also creating a new business model around producing chips for external customers.
Some analysts believe that the equity offering could help reduce the pressure on Intel’s balance sheet as it finances those investments. However, existing shareholders will bear dilution from the new shares, which explains at least part of the negative initial market reaction.
Intel has also granted underwriters a 30-day option to purchase as much as $2.25 billion of additional shares at the offering price, less underwriting discounts. JPMorgan Securities, Goldman Sachs, Morgan Stanley and Citigroup Global Markets are serving as joint book-running managers.
The fund-raising also marks a notable reversal from Intel’s capital allocation strategy of the previous decade. The company spent tens of billions of dollars buying back its own shares while underinvesting in the manufacturing infrastructure needed to maintain its technological lead. It is now asking shareholders for fresh capital to fund precisely the physical expansion required to rebuild that position.
The broader AI boom gives Intel an important opportunity, but it also raises the stakes. Demand for computing infrastructure is expanding rapidly, creating opportunities for CPU suppliers and semiconductor manufacturers. Yet much of the economic value of the AI hardware cycle has accrued to companies such as Nvidia and TSMC, leaving Intel under pressure to demonstrate that its manufacturing turnaround can generate competitive returns.
Intel’s ability to win major external foundry customers will therefore be critical. A successful foundry business would provide a new source of recurring revenue and improve utilization of Intel’s expensive manufacturing facilities. Failure to secure sufficient customers could leave the company carrying substantial fixed costs while competing against established foundry leaders with greater scale.
The $15 billion offering gives Intel additional financial firepower, but it does not by itself resolve the company’s fundamental challenge. Monday’s share sale is therefore both a financing event and a test of confidence in Intel’s recovery. The company is using a dramatically higher share price to fund a manufacturing gamble that could determine whether it returns to the ranks of global semiconductor leaders or remains a distant competitor.
